Aiosyn Mitosis Breast becomes the first AI-powered mitosis detection solution to achieve CE mark certification under IVDR
recent articles
As a second-year medical student, the chairman of pathology at my medical school came to lecture us on inflammation and repair. Among the first chapters in the hallowed Robbins textbook of pathology (which he contributed to both from his...
From Deciphex on LinkedIn: We’re excited to announce that Gary Roche, our Business Development Manager, will be attending the 14th Global Summit on Regulatory Science, hosted by the FDA in Little Rock, Arkansas. Gary will be there to...
From Diagenexia on LinkedIn: Excited to Announce Diagnexia's Participation at the 3rd NHS Pathology Conference: Improving NHS Diagnostics! 📅 25 September, London, hosted by Convenzis Group. We're at the forefront of digital...
Proscia and Fimlab: Unlocking insights that advance precision medicine TAMPERE, Finland and PHILADELPHIA – September 9, 2024 – Fimlab Laboratories, Finland’s largest provider of laboratory services, research, and training, is taking...
ALBUQUERQUE, NM / ACCESSWIRE / September 6, 2024 / The Diagnostics & Research Institute for Pathology at the Medical University of Graz, a leader in personalized patient care and one of the largest hospitals in Austria, has selected...
Proscia customers can leverage over 10 million de-identified pathology images alongside corresponding clinical and genomic data PHILADELPHIA – September 4, 2024 – Life sciences organizations can now tap into de-identified real-world...
